Selected article for: "acute treatment and long term short"

Author: Schapowal, Andreas
Title: Efficacy and safety of Echinaforce® in respiratory tract infections
  • Cord-id: yr7dsktc
  • Document date: 2012_12_20
  • ID: yr7dsktc
    Snippet: Echinaforce® is the standardised extract of Echinacea purpurea from Bioforce, Switzerland. Recent studies show immunomodulation and broad antiviral effects against respiratory tract viruses. Haemagglutinin and Neuraminidase are blocked. In contrast to Oseltamivir no resistance is caused by Echinaforce®. A randomised, double-blind, placebo-controlled study over four months confirms that Echinaforce® supports the immune resistance and acts directly against a series of viruses. Echinaforce® is
    Document: Echinaforce® is the standardised extract of Echinacea purpurea from Bioforce, Switzerland. Recent studies show immunomodulation and broad antiviral effects against respiratory tract viruses. Haemagglutinin and Neuraminidase are blocked. In contrast to Oseltamivir no resistance is caused by Echinaforce®. A randomised, double-blind, placebo-controlled study over four months confirms that Echinaforce® supports the immune resistance and acts directly against a series of viruses. Echinaforce® is efficacious and safe in respiratory tract infections for long-term and short-term prevention as well as for acute treatment.

    Search related documents:
    Co phrase search for related documents
    • active virus and acute treatment: 1, 2, 3
    • acute prevention and long term prevention: 1, 2, 3, 4, 5
    • acute prevention treatment and long term prevention: 1
    • acute treatment and long term prevention: 1